GSK’s (GSK) “Buy” Rating Reaffirmed at Deutsche Bank Aktiengesellschaft

GSK (LON:GSK – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at Deutsche Bank Aktiengesellschaft in a research report issued on Tuesday, MarketBeat.com reports. They currently have a GBX 1,950 ($24.98) price objective on the stock. Deutsche Bank Aktiengesellschaft’s price objective points to a potential upside of 15.03% from the stock’s […]

Leave a Reply

Your email address will not be published.

Previous post American Homes 4 Rent (NYSE:AMH) Lifted to “Hold” at StockNews.com
Next post Capita (LON:CPI) Price Target Cut to GBX 1,800 by Analysts at Royal Bank of Canada